SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001326732-23-000028
Filing Date
2023-09-19
Accepted
2023-09-19 16:31:11
Documents
14
Period of Report
2023-09-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xncr-20230915.htm   iXBRL 8-K 27539
2 EX-99.1 xncr-20230915xexx991.htm EX-99.1 9998
6 xncr-20221107xex99d1001.jpg GRAPHIC 8036
  Complete submission text file 0001326732-23-000028.txt   182128

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20230915.xsd EX-101.SCH 1898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20230915_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20230915_pre.xml EX-101.PRE 13044
8 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20230915_htm.xml XML 2821
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 231264242
SIC: 2834 Pharmaceutical Preparations